Table 2 Cox regression analysis on overall survival and disease-free survival on CC0 patients

Age

1.01 (0.96–1.05)

0.737

1.00 (0.97–1.04)

0.705

Sex (F)

0.77 (0.31–1.83)

0.764

1.20 (0.56–2.56)

0.638

Right colon cancer

2.51 (0.99–6.31)

0.051

2.37 (1.08–5.23)

0.032

PCI > 6

3.57 (1.43–8.92)

0.007

4.48 (1.68–11.9)

0.003

2.87 (1.27–6.45)

0.011

Syncronous carcinomatosis

0.82 (0.34–1.96)

0.652

0.71 (0.33–1.51)

0.380

Preoperative chemotherapy

1.49 (0.57–3.88)

0.415

1.45 (0.63–3.34)

0.377

Postoperative chemotherapy

1.59 (0.37–6.88)

0.530

2.71 (0.64–11.5)

0.176

Syncronous HIPEC

0.50 (0.15–1.70)

0.270

0.49 (0.18–1.28)

0.149

Postoperative complications Clavien-Dindo > 2

0.33 (0.44–2.45)

0.279

0.48 (0.11–2.04)

0.325

Tumor grade

 2

1.07 (0.14–8.30)

0.947

1.89 (0.25–14.4)

0.534

 3

1.21 (0.15–9.50)

0.854

2.23 (0.29–16.9)

0.440

T4 stage

1.13 (0.46–2.76)

0.796

1.04 (0.48–2.26)

0.916

N stage

 1

6.43 (1.25–33.0)

0.026

1.63 (0.49–5.33)

0.421

 2

8.23 (1.86–36.4)

0.005

3.89 (1.50–10.1)

0.005

3.05 (1.78–7.88)

0.022

2.44 (1.11–5.36)

0.027